← Latest Filings

S

Sanofi

Also a 13F filer: see its fund portfolio and quarterly moves →

Open-market buys

1

$5.1M total

Open-market sells

0

$0 total

Tracking since

Aug 2026

Activity timeline

Open-market buy — $5.1M

Attovia Therapeutics, Inc. · Aug 6, 2026

Open-market trades from the last two years.

Holdings as last reported

1,082,855 Common Stock in ATTO

Held indirectly (See footnote) · as of 2026-08-06

672,788 Common Stock in LTGO

Held indirectly (See footnote) · as of 2026-08-10

Companies touched

Latigo Biotherapeutics, Inc.

Attovia Therapeutics, Inc.